The Shamonda virus, which had been identified only in animals for over 60 years, has infected a human in France for the first time and claimed their life.
For the first time, the Shamonda virus, which had been identified only in animals for over 60 years, has claimed a human life. The victim was a 61-year-old man in France who suffered from leukemia and, after being infected with the virus, developed severe brain inflammation and passed away. This incident once again highlights the danger of animal viruses transmitting to humans, although experts emphasize that there is currently no evidence of Shamonda spreading among humans.
The Shamonda virus was first identified in cattle in Nigeria in 1965. This virus is transmitted through the bites of very small insects called biting midges and can infect animals such as cows, sheep, goats, and horses.
Shamonda is usually not fatal to adult animals, but in pregnant animals, it can cause miscarriage, stillbirth, or congenital abnormalities. So far, livestock infection with this virus has been identified in 14 European countries.
According to Scientific American, as reported by TahaSite, the patient was a 61-year-old man who was undergoing treatment for leukemia at a hospital in Lyon, France, and had previously undergone a stem cell transplant. After contracting the Shamonda virus, the man developed severe neurological symptoms, including blindness, confusion, and brain inflammation, or encephalitis. His condition gradually worsened, and he fell into a coma. Finally, on October 9, 2026, after life support was withdrawn, he passed away.
The Shamonda virus was first identified in cattle in Nigeria in 1965 and is primarily transmitted through the bites of biting midges.
Genetic tests identified traces of the virus in the patient's cerebrospinal fluid, urine, and saliva samples. Investigations revealed that the identified virus belongs to one of the two new genetic lineages of Shamonda, known as SHAV-EU1.
French health authorities suspect that the patient was infected by the bite of a biting midge in the east of the country, a region where the virus had previously been identified in animals.
This is the first known case of human infection with the Shamonda virus, and there is currently no vaccine to prevent infection in humans or animals. Despite the death of the first patient, experts say there is currently no evidence to suggest that the Shamonda virus is on the verge of widespread human-to-human transmission.
Grégory Destras, a virologist at Lyon Hospital and one of the report's authors, emphasizes that there are no signs of an increase in human cases yet. He suspects that the virus may have been replicating in the patient's body for several weeks before neurological symptoms appeared.
Shamonda belongs to a group of viruses that also includes the Oropouche virus, the causative agent of the disease known as "sloth fever." Oropouche has the ability to infect humans, but another close relative of Shamonda, the Schmallenberg virus, has not yet been identified in humans despite its spread among livestock.
Natasha Tilson-Lunnell, a virologist at Indiana University, says current data suggests that Shamonda's ability to infect humans may be limited. However, she emphasizes the need for monitoring livestock, insect vectors, and examining human samples.
According to Martin Beer, a virologist at the Friedrich Loeffler Institute in Germany, biting midges can spread this group of viruses, especially during the summer and autumn. As temperatures drop below approximately 12 degrees Celsius, the effective replication of the virus in these insects is disrupted, and the transmission cycle is largely halted.
Experts emphasize that there is currently no evidence of human-to-human transmission of the Shamonda virus, and its exact role in the patient's death requires further investigation.
Researchers do not yet know whether Shamonda has been transmitted to humans before and remained undetected. Examining stored samples from immunocompromised patients and searching for antiviral antibodies in the human population could determine whether mild or asymptomatic cases have occurred in the past.
Currently, only one known case of human infection with Shamonda has been reported, and there is no evidence of direct human-to-human transmission of the virus. However, the identification of the first victim shows that viruses that have been observed only in animals for years may, under certain conditions, also pose a risk to humans.
The research has been published in the journal Eurosurveillance.
Comments